These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 29859237)

  • 21. Gene-environment interaction and maternal arsenic methylation efficiency during pregnancy.
    Gao S; Mostofa MG; Quamruzzaman Q; Rahman M; Rahman M; Su L; Hsueh YM; Weisskopf M; Coull B; Christiani DC
    Environ Int; 2019 Apr; 125():43-50. PubMed ID: 30703610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic polymorphism of As3MT and delayed urinary DMA excretion after organic arsenic intake from oyster ingestion.
    Hwang YH; Chen YH; Su YN; Hsu CC; Chen YH; Yuan TH
    J Environ Monit; 2010 Jun; 12(6):1247-54. PubMed ID: 20532380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-6-adenine-specific DNA methyltransferase 1 (N6AMT1) polymorphisms and arsenic methylation in Andean women.
    Harari F; Engström K; Concha G; Colque G; Vahter M; Broberg K
    Environ Health Perspect; 2013 Jul; 121(7):797-803. PubMed ID: 23665909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic polymorphisms of PPAR gamma, arsenic methylation capacity and breast cancer risk in Mexican women.
    Pineda-Belmontes CP; Hernández-Ramírez RU; Hernández-Alcaraz C; Cebrián ME; López-Carrillo L
    Salud Publica Mex; 2016 Apr; 58(2):220-7. PubMed ID: 27557380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylation.
    Monteiro-Reis S; Leça L; Almeida M; Antunes L; Monteiro P; Dias PC; Morais A; Oliveira J; Henrique R; Jerónimo C
    Eur J Cancer; 2014 Jan; 50(1):226-33. PubMed ID: 24100025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arsenite methyltransferase (AS3MT) polymorphisms and arsenic methylation in children in rural Bangladesh.
    De Loma J; Skröder H; Raqib R; Vahter M; Broberg K
    Toxicol Appl Pharmacol; 2018 Oct; 357():80-87. PubMed ID: 30153448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic variation in arsenic (+3 oxidation state) methyltransferase (AS3MT), arsenic metabolism and risk of basal cell carcinoma in a European population.
    Engström KS; Vahter M; Fletcher T; Leonardi G; Goessler W; Gurzau E; Koppova K; Rudnai P; Kumar R; Broberg K
    Environ Mol Mutagen; 2015 Jan; 56(1):60-9. PubMed ID: 25156000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms in cell cycle regulatory genes, urinary arsenic profile and urothelial carcinoma.
    Chung CJ; Huang CJ; Pu YS; Su CT; Huang YK; Chen YT; Hsueh YM
    Toxicol Appl Pharmacol; 2008 Oct; 232(2):203-9. PubMed ID: 18640142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arsenic methylation and bladder cancer risk in Taiwan.
    Chen YC; Su HJ; Guo YL; Hsueh YM; Smith TJ; Ryan LM; Lee MS; Christiani DC
    Cancer Causes Control; 2003 May; 14(4):303-10. PubMed ID: 12846360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of DNA methylation.
    Zhang L; Xiong G; Fang D; Li X; Liu J; Ci W; Zhao W; Singla N; He Z; Zhou L
    J Exp Clin Cancer Res; 2015 Jan; 34(1):5. PubMed ID: 25613404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations between arsenic (+3 oxidation state) methyltransferase (AS3MT) and N-6 adenine-specific DNA methyltransferase 1 (N6AMT1) polymorphisms, arsenic metabolism, and cancer risk in a chilean population.
    de la Rosa R; Steinmaus C; Akers NK; Conde L; Ferreccio C; Kalman D; Zhang KR; Skibola CF; Smith AH; Zhang L; Smith MT
    Environ Mol Mutagen; 2017 Jul; 58(6):411-422. PubMed ID: 28640505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deduction of Novel Genes Potentially Involved in Upper Tract Urothelial Carcinoma Using Next-Generation Sequencing and Bioinformatics Approaches.
    Lee HY; Chen YJ; Li CC; Li WM; Hsu YL; Yeh HC; Ke HL; Huang CN; Li CF; Wu WJ; Kuo PL
    Int J Med Sci; 2019; 16(1):93-105. PubMed ID: 30662333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolomic profiles of arsenic (+3 oxidation state) methyltransferase knockout mice: effect of sex and arsenic exposure.
    Huang MC; Douillet C; Su M; Zhou K; Wu T; Chen W; Galanko JA; Drobná Z; Saunders RJ; Martin E; Fry RC; Jia W; Stýblo M
    Arch Toxicol; 2017 Jan; 91(1):189-202. PubMed ID: 26883664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of genetic polymorphisms on arsenic methylation efficiency during pregnancy: Evidence from a Spanish birth cohort.
    Soler-Blasco R; Harari F; Riutort-Mayol G; Murcia M; Lozano M; Irizar A; Marina LS; Zubero MB; Fernández-Jimenez N; Braeuer S; Ballester F; Llop S
    Sci Total Environ; 2023 Nov; 900():165740. PubMed ID: 37495132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Arsenic (+3 Oxidation State) Methyltransferase Gene Polymorphisms and Expression on Bladder Cancer: Evidence from a Systematic Review, Meta-analysis and TCGA Dataset.
    Song Y; Jin D; Chen J; Liang W; Liu X
    Toxicol Sci; 2020 Sep; 177(1):27-40. PubMed ID: 32539094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of sodium arsenite dose administered in the drinking water on the urinary bladder epithelium of female arsenic (+3 oxidation state) methyltransferase knockout mice.
    Yokohira M; Arnold LL; Pennington KL; Suzuki S; Kakiuchi-Kiyota S; Herbin-Davis K; Thomas DJ; Cohen SM
    Toxicol Sci; 2011 Jun; 121(2):257-66. PubMed ID: 21385732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developmentally restricted genetic determinants of human arsenic metabolism: association between urinary methylated arsenic and CYT19 polymorphisms in children.
    Meza MM; Yu L; Rodriguez YY; Guild M; Thompson D; Gandolfi AJ; Klimecki WT
    Environ Health Perspect; 2005 Jun; 113(6):775-81. PubMed ID: 15929903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global gene expression profiling identifies ALDH2, CCNE1 and SMAD3 as potential prognostic markers in upper tract urothelial carcinoma.
    Wu S; Chen J; Dong P; Zhang S; He Y; Sun L; Zhu J; Cheng Y; Li X; Tang A; Huang Y; Gui Y; Liu C; Yang G; Zhou F; Cai Z; Wang R
    BMC Cancer; 2014 Nov; 14():836. PubMed ID: 25408144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disruption of the arsenic (+3 oxidation state) methyltransferase gene in the mouse alters the phenotype for methylation of arsenic and affects distribution and retention of orally administered arsenate.
    Drobna Z; Naranmandura H; Kubachka KM; Edwards BC; Herbin-Davis K; Styblo M; Le XC; Creed JT; Maeda N; Hughes MF; Thomas DJ
    Chem Res Toxicol; 2009 Oct; 22(10):1713-20. PubMed ID: 19691357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between polymorphisms in arsenic metabolism genes and urinary arsenic methylation profiles in girls and boys chronically exposed to arsenic.
    Recio-Vega R; González-Cortes T; Olivas-Calderón E; Clark Lantz R; Jay Gandolfi A; Michel-Ramirez G
    Environ Mol Mutagen; 2016 Aug; 57(7):516-25. PubMed ID: 27327299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.